CVS Health Corporation (NYSE: CVS) was highlighted by Jim Cramer as one of the best performing healthcare stocks, with an impressive 77% increase in value under new CEO David Joyner. The company’s competitor, Walgreens, is facing closures, further boosting CVS’s position in the market. Cramer sees potential for another strong year ahead for CVS. Meanwhile, CVS offers healthcare solutions through insurance, pharmacy benefit management, and retail services. The company’s stock has seen a 2% increase following positive long-term earnings targets. Considered a solid investment, some believe other AI stocks may offer even greater potential.

Read more at Yahoo Finance: Jim Cramer on CVS CEO: “Joyner’s Money”